Clinical Trial Update: Polydeoxyribonucleotide (PDRN) for Cuff Regeneration [Phase 4]

View source ↗

Summary

Phase 4 trial update for polydeoxyribonucleotide (PDRN) in rotator cuff tear regeneration has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• Polydeoxyribonucleotide (PDRN) (polydeoxyribonucleotide)

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Rotator Cuff Tear | Phase 4 | Status: COMPLETED